Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001127602-19-029433
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-01 17:07:10
Reporting Period:
2019-09-30
Accepted Time:
2019-10-01 17:07:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64803 Cvs Health Corp CVS Retail-Drug Stores And Proprietary Stores (5912) 050494040
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1412223 Matthew Joshua Flum One Cvs Drive
Woonsocket RI 02895
Evp, Ent Strategy & Digital No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-30 17,703 $54.53 36,163 No 4 M Direct
Common Stock Disposition 2019-09-30 17,703 $63.00 18,460 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2019-09-30 17,703 $0.00 17,703 $54.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-04-01 2020-04-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock (Pep) 2,683 Direct
Common Stock (Restricted) 15,324 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $34.96 2014-04-01 2021-04-01 21,460 21,460 Direct
Common Stock Stock Option $74.29 2015-04-01 2021-04-01 25,177 25,177 Direct
Common Stock Stock Option $102.26 2016-04-01 2022-04-01 17,822 17,822 Direct
Common Stock Stock Option $104.82 2017-04-01 2023-04-01 17,611 17,611 Direct
Common Stock Stock Option $103.87 2018-02-27 2025-02-27 24,060 24,060 Direct
Common Stock Stock Option $78.05 2018-04-03 2024-04-03 30,169 30,169 Direct
Common Stock Stock Option $62.21 2019-04-01 2025-04-01 22,541 22,541 Direct
Common Stock Stock Option $54.19 2020-04-01 2029-04-01 60,602 60,602 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-04-01 21,460 21,460 Direct
2021-04-01 25,177 25,177 Direct
2022-04-01 17,822 17,822 Direct
2023-04-01 17,611 17,611 Direct
2025-02-27 24,060 24,060 Direct
2024-04-03 30,169 30,169 Direct
2025-04-01 22,541 22,541 Direct
2029-04-01 60,602 60,602 Direct
Footnotes
  1. All sales were effected pursuant to a Rule 10b5-1 plan.
  2. Options became exercisable in four equal annual installments beginning on 4/1/2014.
  3. Options became exercisable in three equal annual installments beginning on 4/1/2014.
  4. Options became exercisable in four equal annual installments beginning on 4/1/2015.
  5. Options became exercisable in four equal annual installments beginning on 4/1/2016.
  6. Options became exercisable in four equal annual installments beginning on 4/1/2017.
  7. Options became exercisable in three equal annual installments beginning on 2/27/2018.
  8. Options became exercisable in four equal annual installments beginning on 4/3/2018.
  9. Option became exercisable in four equal annual installments, commencing 4/1/2019.
  10. Option becomes exercisable in four equal annual installments, commencing 4/1/2020.